With regard to South Korea, Novartis settled selected perfectly-publicized allegations that it had made inappropriate payments to HCPs in South Korea by way of round tables and third-bash healthcare journals. Novartis Korea allegedly transmitted improper honoraria to HCPs for spherical tables as a result of healthcare journals to avoid compliance s